Drs. Leora Horn, Ben Solomon, & Jack West discuss the open question of whether there are clinically significant differences among leading EGFR tyrosine kinases based on the specific EGFR mutation to be treated.
Does the Specific EGFR Mutation Matter When Choosing an Oral EGFR Inhibitor_ [360p]
